SFRP2 and lung carcinoma: Other studies also reported that sFRP2 can activate the canonical Wnt signaling pathway in different cell types and disease models, including lung cancer cells 15, dermal papilla cells 16, intestinal epithelial cells 17, the vertebrate optic disc 18, and cardiac fibroblast cells 19.